Furthermore, the degree of MDR-Os infection was all the higher, the longer was the antibiotic treatment used to overcome the original infection: in our series only 8.5% of the MDR-Os-SSI infections was poly-microbial at presentation, but a further 29.7% became MDR-Os poly-microbial during the clinical course. This evidence concerns the gene MID1 and infection.